Merck nears $6bn biotech deal to boost cancer drug pipeline

  • Posted on March 25, 2026
  • By Financial Times
  • 3 Views
Merck nears $6bn biotech deal to boost cancer drug pipeline

Terns Pharma stock has jumped since promising clinical data on its bone and blood cancer treatment last year
continue reading...

Author
Financial Times

You May Also Like